放射性药物市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围:按应用、类型、示踪剂类型、最终用户和地理位置
市场调查报告书
商品编码
1498536

放射性药物市场规模和预测、全球和区域份额、趋势和成长机会分析报告范围:按应用、类型、示踪剂类型、最终用户和地理位置

Radiopharmaceuticals Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application, Type, Tracer Type, End User, and Geography

出版日期: | 出版商: The Insight Partners | 英文 237 Pages | 订单完成后即时交付

价格

放射性药物市场规模预计将从2023年的90.7亿美元激增至2031年的265.1亿美元;预计 2023 年至 2031 年市场复合年增长率为 14.4%。慢性病盛行率的上升和标靶治疗临床试验数量的增加推动了放射性药物市场的成长。

放射性药物已被证明可以有效诊断和治疗与年龄相关的疾病。放射性药物的开发具有改进的靶向能力、更长的半衰期和更少的副作用,这使得它们对各种应用更具吸引力。将诊断和治疗功能结合在单一放射性药物中的治疗诊断学研究前景广阔,可以进一步推动市场成长。随着世界各国政府认识到放射性药物在改善健康结果方面的价值,新放射性药物的研究和开发资金以及批准其支持性监管途径的资金增加。此外,市场正在朝着满足不断变化的医疗保健环境的需求的方向发展,并且使用先进诊断技术的不断发展的放射性製药设施预计将在未来几年带来新的放射性药物市场趋势。

慢性病盛行率上升推动放射性药物市场

肺病、癌症、中风、阿兹海默症、心血管疾病(CVD)、慢性肾臟病和各种神经系统疾病等慢性疾病在世界各地迅速增加。根据世界卫生组织 (WHO) 统计,2020 年,全球约有 1,000 万人因癌症死亡。同样,根据美国癌症协会的估计,2020 年,美国新诊断出约 1,806,590 例癌症病例。根据 2020 年国家癌症登记计画报告,印度报告了 679,421 例男性癌症病例,预计到 2025 年将增加至约 763,575 例;而在女性中,2020年记录了712,758例癌症病例,预计到2025年这一数字将达到806,218例。男性12,540例)被记录下来。心血管疾病是最常见的慢性疾病类型之一,死亡率很高。美国疾病管制与预防中心表示,心臟病是美国的首要死因。据同一消息来源称,2020 年,美国约有 697,000 人死亡,即五分之一的死亡是由心臟病引起的。据帕金森氏症基金会称,帕金森氏症症状通常出现在 60 岁及以上的人群中。加拿大心理学会指出,加拿大约有2%的人口患有强迫症。根据世界卫生组织的数据,神经系统疾病占全球疾病负担的 6.3%,也是全球死亡的主要原因之一。据报导,已开发国家和低收入和中等收入国家的死亡人数分别有 13.2% 和 16.8% 是由神经系统疾病引起的。放射性药物已被证明在诊断神经系统和神经退化性疾病以及肌肉骨骼疾病方面具有高效性。放射性药物因其双重功能而与众不同。它们不仅增强了疾病的可视化,还提供了重要的功能资讯。在各种可用的方法中,放射性同位素细胞标记是追踪细胞以研究其生物分布的最有前途的技术之一。因此,慢性病发病率的飙升正在推动放射性药物市场的成长。

市场趋势

不断发展的放射性药物设施

核子医学是一个正在经历许多变化的领域。随着放射性药物的快速发展,PET 和放射治疗等更先进的诊断技术正在得到更广泛的应用。在低收入国家,由于国际原子能机构(IAEA)的努力,该技术仍在建立中,而在美国等一些技术先进国家,该技术正在演变成标准护理,特别是随着治疗诊断的出现。

一些非洲国家正在原子能机构技术合作规划和协调研究计画的帮助下,努力扩大其放射性药物设施并使其现代化,以生产放射性药物。例如,在国际原子能总署的支持下,北非国家突尼斯开始使用PET。同时,在阿尔及利亚,一台医用迴旋加速器安装并投入运作。该机器使该国能够生产放射性药物,并能够对淋巴瘤、肺癌和结肠癌等多种癌症进行常规 PET 成像。

放射性药物趋势国际研讨会展示了放射性药物化学和核子医学的光明前景。同位素生产、放射化学以及新型放射性药物在人体研究中的应用的进步带来了令人兴奋的结果。特别是,使用影像指导标靶治疗的治疗诊断策略以及不断发展的研究领域正在帮助全球核子医学界透过开发新的放射治疗方法实现个人化医疗的潜力。治疗诊断学将诊断和治疗融为一体。放射性示踪剂可识别特定目标(诊断),然后进行标靶治疗。这种方法可以让医生透过即时评估患者对治疗的反应来为患者制定个人化治疗计划。治疗诊断对于治疗某些形式的癌症特别有希望,例如前列腺癌和神经内分泌肿瘤。借助新的放射性示踪剂和显影剂,分子影像变得更加特异和灵敏,从而能够更早、更准确地检测疾病。此外,混合影像(例如 PET-CT 和 PET-MRI)结合了两种或多种影像模式,以提供互补资讯并提高诊断准确性。这些方法结合了功能和解剖讯息,能够全面概述疾病过程。因此,此类发展和方法预计将推动未来的市场成长。

「全球放射性药物市场」根据应用、示踪剂类型、最终用户和地理位置进行细分。

基于应用程式的见解

根据应用,放射性药物市场分析是透过考虑以下细分市场进行的:肿瘤学、心臟病学、神经学、肺病学、泌尿学等。肿瘤学领域在 2023 年占据最大的市场份额,预计在预测期内复合年增长率最高为 14.8%。癌症是死亡率较高的主要健康问题之一。根据世界卫生组织的数据,2020 年,全球估计新诊断出 1,010 万癌症病例,1,000 万人死于癌症。癌症患者的诊断和治疗需要影像学检查以确保准确的管理决策和最佳结果。核子医学疗法用于治疗癌症,最常见的放射性追踪剂是F-18氟脱氧葡萄糖(FDG)。 FDG与葡萄糖相似,癌细胞代谢较活跃;因此,它们以更高的速度吸收葡萄糖。这可以在 PET 扫描中看到,从而使医疗保健专业人员能够检测到疾病。标记为氟脱氧葡萄糖的氟-i8 可有效区分恶性与良性肿瘤以及确定疾病的程度。 2018 年 1 月 FDA 批准镥 Lu 177 dotatate (Lutathera) 后,神经内分泌肿瘤 (NET) 患者可以更广泛地接受 PRRT。

基于最终用户的见解

按最终用户划分,市场分为医院和诊所、诊断中心、学术和研究机构等。 2023 年,医院和诊所领域在放射性药物市场份额中占据主导地位。医院和诊所利用技术先进的方法治疗心臟动脉瘤、肿瘤肿瘤、神经动脉瘤和其他治疗程序。对心血管和神经动脉瘤治疗的需求不断增长已成为推动医院和诊所市场成长的主要因素之一。由于持续的患者护理和监测,大多数手术都在医院进行。

美国食品药物管理局、欧盟、世界卫生组织、国际原子能机构、疾病管制与预防中心、国家癌症研究所、国家医疗产品管理局、经济合作暨发展组织和加拿大核安委员会等准备放射性药物市场研究报告时参考的相关来源。

目录

第 1 章:简介

第 2 章:执行摘要

  • 重要见解

第 3 章:研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章:放射性药物市场格局

  • 概述
  • PEST分析
  • 定价分析
    • 区域定价分析,美元(每剂)

第 5 章:放射性药物市场 - 主要市场动态

  • 放射性药物市场 - 主要市场动态
  • 市场驱动因素
    • 慢性病盛行率上升
    • 标靶治疗的临床试验数量不断增加
  • 市场限制
    • 放射性药物的保存期限短
  • 市场机会
    • 发展中国家的高成长潜力
  • 未来的趋势
    • 不断发展的放射性药物设施
  • 驱动因素和限制的影响:

第 6 章:放射性药物市场 - 全球市场分析

  • 放射性药物市场收入,2023-2031

第 7 章:放射性药物市场分析 - 按应用

  • 概述
  • 肿瘤学
  • 心臟病学
  • 神经病学
  • 肺部
  • 泌尿科
  • 其他的

第 8 章:放射性药物市场分析 - 按类型

  • 概述
  • 诊断
  • 治疗性

第 9 章:放射性药物市场分析 - 按示踪剂类型

  • 概述
  • Tc-99m
  • F-18
  • Ga-68
  • TL-201
  • I-131
  • 铁59
  • 卢-171
  • RB-82 和 N-13
  • Cr-51 和 P-32
  • SC-46
  • SG-269 和 Hs-269
  • 其他的

第 10 章:放射性药物市场分析 - 按最终用户

  • 概述
  • 医院和诊所
  • 诊断中心
  • 学术及研究机构
  • 其他的

第 11 章:放射性药物市场 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章:放射性药物市场-产业格局

  • 概述
  • 放射性药物市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 13 章:公司简介

  • Cardinal Health Inc
  • Curium
  • General Electric Co
  • Medi-Radiopharma
  • Rotem Industries Ltd
  • ABX advanced biochemical compounds GmbH
  • Invicro LLC
  • Newcastle University
  • Novartis AG
  • Blue Earth Diagnostics Limited
  • IBA Radiopharma Solutions

第 14 章:附录

Product Code: TIPRE00003751

The radiopharmaceuticals market size is projected to surge from US$ 9.07 billion in 2023 to US$ 26.51 billion by 2031; the market is estimated to record a CAGR of 14.4% during 2023-2031. The rising prevalence of chronic diseases and the growing number of clinical trials in targeted therapy propel the radiopharmaceuticals market growth.

Radiopharmaceuticals have proven to handle the diagnosis and treatment of age-related diseases efficiently. The development of radiopharmaceuticals with improved targeting capabilities, longer half-lives, and fewer side effects makes them more attractive for various applications. Research into theranostics that combine diagnostic and therapeutic functions in a single radiopharmaceutical is promising and could further drive the market growth. As governments across the world recognize the value of radiopharmaceuticals in improving health outcomes, an increase in the funding for research and development of new radiopharmaceuticals and supportive regulatory pathways for their approval has been observed. Further, the market is progressing toward meeting the demands of a changing healthcare landscape, and the evolving radiopharmacy facilities using advanced diagnostic techniques are expected to bring new radiopharmaceuticals market trends in the coming years.

Rising Prevalence of Chronic Diseases Drives the Radiopharmaceuticals Market

Chronic diseases such as lung diseases, cancer, stroke, Alzheimer's, cardiovascular diseases (CVDs), chronic kidney disease, and various neurological disorders are increasing swiftly across the world. As per the World Health Organization (WHO), in 2020, ~10 million deaths were reported due to cancer globally. Likewise, as per the estimations of the American Cancer Society, in 2020, ~1,806,590 new cases of cancer were diagnosed in the US. As per the National Cancer Registry Program Report 2020, in India, 679,421 cancer cases were reported in males, and the number is anticipated to increase to ~763,575 by 2025; whereas in females, 712,758 cancer cases were recorded in 2020, and the number is predicted to reach 806,218 by 2025. According to the American Cancer Society's report, in 2023, ~43,720 new cases of thyroid cancer (31,180 in women and 12,540 in men) were recorded. CVDs are among the most prevalent types of chronic diseases that result in a high mortality rate. The Centers for Disease Control and Prevention states that heart disease is the leading cause of death in the US. According to the same source, in 2020, ~697,000 deaths, i.e., 1 in 5 deaths, were caused by heart disease in the US. According to the Parkinson's Foundation, Parkinson's symptoms are usually observed in individuals aged 60 years and above. The Canadian Psychological Association states that about 2% of the population in Canada suffers from obsessive-compulsive disorder. As per the WHO, neurological diseases contribute to 6.3% of the global disease burden and are also among the leading causes of death worldwide. 13.2% and 16.8% of deaths are reported due to neurological diseases in developed and low- and middle-income countries, respectively. Radiopharmaceuticals have been demonstrated to have high efficiency in diagnosing neurological and neurodegenerative disorders and musculoskeletal conditions. Radiopharmaceuticals are set apart due to their dual functionality. They not only enhance the visualization of diseases but also provide crucial functional information. Among the various methods available, radioisotope cell labeling is one of the most promising techniques to track cells to investigate their biodistribution. Thus, the surging incidence of chronic diseases is driving the radiopharmaceuticals market growth.

Market Trend

Evolving Radiopharmacy Facilities

Nuclear medicine is a field that is undergoing many changes. As radiopharmaceuticals evolve rapidly, more advanced diagnostic techniques such as PET and radiotherapeutics are becoming more widely used. In low-income countries, the technology is still being established, owing to the efforts by the International Atomic Energy Agency (IAEA), while in some of the technologically advanced countries such as the US, it is evolving into standard care, particularly with the advent of theranostics.

Several African countries are working toward expanding and modernizing their radiopharmaceutical facilities to produce radiopharmaceutical medicines with the help of IAEA's Technical Cooperation Program and coordinated research projects. For instance, with IAEA's support, Tunisia, a country in North Africa, started using PET. At the same time, in Algeria, a medical cyclotron was installed and commissioned. The machine enables the country to produce its radiopharmaceuticals and enables routine PET imaging for many types of cancer, such as lymphoma and lung and colon cancer.

The International Symposium on Trends in Radiopharmaceuticals showcases the bright future of radiopharmaceutical chemistry and nuclear medicine. Advances in isotope production, radiochemistry, and the implementation of novel radiopharmaceuticals in human studies lead to exciting results. In particular, theranostic strategies, which use imaging to guide targeted therapy, and the growing areas of research are helping the global nuclear medicine community realize the potential of personalized medicine through the development of new radiotherapeutics. Theranostics merges diagnostics and therapy in a single approach. Radioactive tracers identify specific targets (diagnosis) and then perform targeted therapies. This approach lets physicians personalize treatment plans for patients by assessing their response to therapy in real time. Theranostics are particularly promising for the treatment of certain forms of cancer, such as prostate cancer and neuroendocrine tumors. With new radiotracers and imaging agents, molecular imaging is becoming more specific and sensitive, enabling earlier and more accurate disease detection. In addition, hybrid imaging, such as PET-CT and PET-MRI, combines two or more imaging modalities to provide complementary information and improve diagnostic accuracy. These approaches combine functional and anatomical information, enabling a comprehensive overview of disease processes. Therefore, such developments and approaches are expected to drive the market growth in the future.

The "Global Radiopharmaceuticals Market" is segmented on the basis of application, tracer type, end user, and geography.

Application-Based Insights

Based on application, the radiopharmaceuticals market analysis is carried out by considering the following segments: oncology, cardiology, neurology, pulmonary, urology, and others. The oncology segment held the largest market share in 2023 and is anticipated to register the highest CAGR of 14.8% during the forecast period. Cancer is one of the major health problems with a high mortality rate. As per the WHO, in 2020, an estimated 10.1 million new cancer cases were diagnosed, and 10 million people died from cancer worldwide. The diagnosis and treatment of patients with cancer require access to imaging to ensure accurate management decisions and optimal outcomes. Nuclear medicine therapy is used to treat cancer, and the most common radiotracer is F-18 fluorodeoxyglucose (FDG). FDG is similar to glucose, and cancer cells are more metabolically active; therefore, they absorb glucose at a higher rate. This can be seen on PET scans and thereby allows the healthcare professional to detect the disease. Fluorine-i8 labeled as flurodeoxyglucose is effective in differentiating malignant from benign tumors and in determining the extent of the disease. People with neuroendocrine tumors (NETs) have wider access to PRRT following the FDA approval of lutetium Lu 177 dotatate (Lutathera) in January 2018.

End User-Based Insights

By end user, the market is segmented into hospitals and clinics, diagnostic centers, academic and research institutes, and others. The hospitals and clinics segment dominated the radiopharmaceuticals market share in 2023. The diagnostic centers segment is anticipated to register the highest CAGR of 14.8% during 2023-2031. Hospitals and clinics utilize technologically advanced treatment for cardiac aneurysms, oncology tumors, neurology aneurysms, and other treatment procedures. The growing need for cardiovascular and neurology aneurysm treatments has become one of the major factors driving the market growth for the hospitals and clinics segment. Most of the surgeries are being performed in hospitals, owing to the continuous patient care and monitoring.

US Food and Drug Administration, European Union, World Health Organization, International Atomic Energy Agency, Centers For Disease Control And Prevention, National Cancer Institute, National Medical Products Administration, Organization For Economic Co-Operation And Development, and Canadian Nuclear Safety Commission are some of the relevant sources referred while preparing the radiopharmaceuticals market research report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Radiopharmaceuticals Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Pricing Analysis
    • 4.3.1 Regional Pricing Analysis, US$ (Per Dose)

5. Radiopharmaceuticals Market - Key Market Dynamics

  • 5.1 Radiopharmaceuticals Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Rising Prevalence of Chronic Diseases
    • 5.2.2 Growing Number of Clinical Trials in Targeted Therapy
  • 5.3 Market Restraints
    • 5.3.1 Short Shelf-Life of Radiopharmaceuticals
  • 5.4 Market Opportunities
    • 5.4.1 High Growth Potential in Developing Countries
  • 5.5 Future Trends
    • 5.5.1 Evolving Radiopharmacy Facilities
  • 5.6 Impact of Drivers and Restraints:

6. Radiopharmaceuticals Market - Global Market Analysis

  • 6.1 Radiopharmaceuticals Market Revenue (US$ Million), 2023-2031

7. Radiopharmaceuticals Market Analysis - by Application

  • 7.1 Overview
  • 7.2 Oncology
    • 7.2.1 Overview
    • 7.2.2 Oncology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cardiology
    • 7.3.1 Overview
    • 7.3.2 Cardiology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Neurology
    • 7.4.1 Overview
    • 7.4.2 Neurology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Pulmonary
    • 7.5.1 Overview
    • 7.5.2 Pulmonary: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Urology
    • 7.6.1 Overview
    • 7.6.2 Urology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)

8. Radiopharmaceuticals Market Analysis - by Type

  • 8.1 Overview
  • 8.2 Diagnostic
    • 8.2.1 Overview
    • 8.2.2 Diagnostic: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
      • 8.2.2.1 Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - By Diagnostic
  • 8.3 Therapeutic
    • 8.3.1 Overview
    • 8.3.2 Therapeutic: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
      • 8.3.2.1 Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - By Therapeutic

9. Radiopharmaceuticals Market Analysis - by Tracer Type

  • 9.1 Overview
  • 9.2 Tc-99m
    • 9.2.1 Overview
    • 9.2.2 Tc-99m: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
      • 9.2.2.1 Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - By Tc-99m
  • 9.3 F-18
    • 9.3.1 Overview
    • 9.3.2 F-18: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Ga-68
    • 9.4.1 Overview
    • 9.4.2 Ga-68: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 TL-201
    • 9.5.1 Overview
    • 9.5.2 TL-201: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 I-131
    • 9.6.1 Overview
    • 9.6.2 I-131: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Fe-59
    • 9.7.1 Overview
    • 9.7.2 Fe-59: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Lu-171
    • 9.8.1 Overview
    • 9.8.2 Lu-171: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.9 RB-82 and N-13
    • 9.9.1 Overview
    • 9.9.2 RB-82 and N-13: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.10 Cr-51 and P-32
    • 9.10.1 Overview
    • 9.10.2 Cr-51 and P-32: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.11 Sc-46
    • 9.11.1 Overview
    • 9.11.2 Sc-46: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.12 Sg-269 and Hs-269
    • 9.12.1 Overview
    • 9.12.2 Sg-269 and Hs-269: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.13 Others
    • 9.13.1 Overview
    • 9.13.2 Others: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)

10. Radiopharmaceuticals Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals and Clinics
    • 10.2.1 Overview
    • 10.2.2 Hospitals and Clinics: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Diagnostic Centers
    • 10.3.1 Overview
    • 10.3.2 Diagnostic Centers: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Academic and Research Institutes
    • 10.4.1 Overview
    • 10.4.2 Academic and Research Institutes: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)

11. Radiopharmaceuticals Market - Geographical Analysis

  • 11.1 Overview
  • 11.2 North America
    • 11.2.1 North America Radiopharmaceuticals Market Overview
    • 11.2.2 North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.2.3 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Application
    • 11.2.4 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Type
      • 11.2.4.1 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Diagnostic
      • 11.2.4.2 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Therapeutic
    • 11.2.5 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tracer Type
      • 11.2.5.1 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tc-99m
    • 11.2.6 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by End User
    • 11.2.7 North America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Country
      • 11.2.7.1 United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.7.1.1 United States: Radiopharmaceuticals Market Breakdown, by Application
        • 11.2.7.1.2 United States: Radiopharmaceuticals Market Breakdown, by Type
        • 11.2.7.1.2.1 United States: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.2.7.1.2.2 United States: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.2.7.1.3 United States: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.2.7.1.3.1 United States: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.2.7.1.4 United States: Radiopharmaceuticals Market Breakdown, by End User
      • 11.2.7.2 Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.7.2.1 Canada: Radiopharmaceuticals Market Breakdown, by Application
        • 11.2.7.2.2 Canada: Radiopharmaceuticals Market Breakdown, by Type
        • 11.2.7.2.2.1 Canada: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.2.7.2.2.2 Canada: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.2.7.2.3 Canada: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.2.7.2.3.1 Canada: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.2.7.2.4 Canada: Radiopharmaceuticals Market Breakdown, by End User
      • 11.2.7.3 Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.2.7.3.1 Mexico: Radiopharmaceuticals Market Breakdown, by Application
        • 11.2.7.3.2 Mexico: Radiopharmaceuticals Market Breakdown, by Type
        • 11.2.7.3.2.1 Mexico: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.2.7.3.2.2 Mexico: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.2.7.3.3 Mexico: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.2.7.3.3.1 Mexico: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.2.7.3.4 Mexico: Radiopharmaceuticals Market Breakdown, by End User
  • 11.3 Europe
    • 11.3.1 Europe Radiopharmaceuticals Market Overview
    • 11.3.2 Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
    • 11.3.3 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Application
    • 11.3.4 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Type
      • 11.3.4.1 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Diagnostic
      • 11.3.4.2 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Therapeutic
    • 11.3.5 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tracer Type
      • 11.3.5.1 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tc-99m
    • 11.3.6 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by End User
    • 11.3.7 Europe: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Country
      • 11.3.7.1 Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.7.1.1 Germany: Radiopharmaceuticals Market Breakdown, by Application
        • 11.3.7.1.2 Germany: Radiopharmaceuticals Market Breakdown, by Type
        • 11.3.7.1.2.1 Germany: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.3.7.1.2.2 Germany: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.3.7.1.3 Germany: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.3.7.1.3.1 Germany: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.3.7.1.4 Germany: Radiopharmaceuticals Market Breakdown, by End User
      • 11.3.7.2 United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.7.2.1 United Kingdom: Radiopharmaceuticals Market Breakdown, by Application
        • 11.3.7.2.2 United Kingdom: Radiopharmaceuticals Market Breakdown, by Type
        • 11.3.7.2.2.1 United Kingdom: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.3.7.2.2.2 United Kingdom: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.3.7.2.3 United Kingdom: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.3.7.2.3.1 United Kingdom: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.3.7.2.4 United Kingdom: Radiopharmaceuticals Market Breakdown, by End User
      • 11.3.7.3 France: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.7.3.1 France: Radiopharmaceuticals Market Breakdown, by Application
        • 11.3.7.3.2 France: Radiopharmaceuticals Market Breakdown, by Type
        • 11.3.7.3.2.1 France: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.3.7.3.2.2 France: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.3.7.3.3 France: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.3.7.3.3.1 France: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.3.7.3.4 France: Radiopharmaceuticals Market Breakdown, by End User
      • 11.3.7.4 Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.7.4.1 Italy: Radiopharmaceuticals Market Breakdown, by Application
        • 11.3.7.4.2 Italy: Radiopharmaceuticals Market Breakdown, by Type
        • 11.3.7.4.2.1 Italy: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.3.7.4.2.2 Italy: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.3.7.4.3 Italy: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.3.7.4.3.1 Italy: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.3.7.4.4 Italy: Radiopharmaceuticals Market Breakdown, by End User
      • 11.3.7.5 Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.7.5.1 Spain: Radiopharmaceuticals Market Breakdown, by Application
        • 11.3.7.5.2 Spain: Radiopharmaceuticals Market Breakdown, by Type
        • 11.3.7.5.2.1 Spain: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.3.7.5.2.2 Spain: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.3.7.5.3 Spain: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.3.7.5.3.1 Spain: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.3.7.5.4 Spain: Radiopharmaceuticals Market Breakdown, by End User
      • 11.3.7.6 Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.3.7.6.1 Rest of Europe: Radiopharmaceuticals Market Breakdown, by Application
        • 11.3.7.6.2 Rest of Europe: Radiopharmaceuticals Market Breakdown, by Type
        • 11.3.7.6.2.1 Rest of Europe: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.3.7.6.2.2 Rest of Europe: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.3.7.6.3 Rest of Europe: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.3.7.6.3.1 Rest of Europe: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.3.7.6.4 Rest of Europe: Radiopharmaceuticals Market Breakdown, by End User
  • 11.4 Asia Pacific
    • 11.4.1 Asia Pacific Radiopharmaceuticals Market Overview
    • 11.4.2 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.4.2.1 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Application
      • 11.4.2.2 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Type
        • 11.4.2.2.1 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Diagnostic
        • 11.4.2.2.2 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Therapeutic
      • 11.4.2.3 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tracer Type
        • 11.4.2.3.1 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tc-99m
      • 11.4.2.4 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by End User
    • 11.4.3 Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Country
      • 11.4.3.1 China: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.1.1 China: Radiopharmaceuticals Market Breakdown, by Application
        • 11.4.3.1.2 China: Radiopharmaceuticals Market Breakdown, by Type
        • 11.4.3.1.2.1 China: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.4.3.1.2.2 China: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.4.3.1.3 China: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.4.3.1.3.1 China: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.4.3.1.4 China: Radiopharmaceuticals Market Breakdown, by End User
      • 11.4.3.2 Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.2.1 Japan: Radiopharmaceuticals Market Breakdown, by Application
        • 11.4.3.2.2 Japan: Radiopharmaceuticals Market Breakdown, by Type
        • 11.4.3.2.2.1 Japan: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.4.3.2.2.2 Japan: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.4.3.2.3 Japan: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.4.3.2.3.1 Japan: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.4.3.2.4 Japan: Radiopharmaceuticals Market Breakdown, by End User
      • 11.4.3.3 India: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.3.1 India: Radiopharmaceuticals Market Breakdown, by Application
        • 11.4.3.3.2 India: Radiopharmaceuticals Market Breakdown, by Type
        • 11.4.3.3.2.1 India: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.4.3.3.2.2 India: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.4.3.3.3 India: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.4.3.3.3.1 India: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.4.3.3.4 India: Radiopharmaceuticals Market Breakdown, by End User
      • 11.4.3.4 Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.4.1 Australia: Radiopharmaceuticals Market Breakdown, by Application
        • 11.4.3.4.2 Australia: Radiopharmaceuticals Market Breakdown, by Type
        • 11.4.3.4.2.1 Australia: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.4.3.4.2.2 Australia: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.4.3.4.3 Australia: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.4.3.4.3.1 Australia: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.4.3.4.4 Australia: Radiopharmaceuticals Market Breakdown, by End User
      • 11.4.3.5 South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.5.1 South Korea: Radiopharmaceuticals Market Breakdown, by Application
        • 11.4.3.5.2 South Korea: Radiopharmaceuticals Market Breakdown, by Type
        • 11.4.3.5.2.1 South Korea: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.4.3.5.2.2 South Korea: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.4.3.5.3 South Korea: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.4.3.5.3.1 South Korea: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.4.3.5.4 South Korea: Radiopharmaceuticals Market Breakdown, by End User
      • 11.4.3.6 Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.4.3.6.1 Rest of APAC: Radiopharmaceuticals Market Breakdown, by Application
        • 11.4.3.6.2 Rest of APAC: Radiopharmaceuticals Market Breakdown, by Type
        • 11.4.3.6.2.1 Rest of APAC: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.4.3.6.2.2 Rest of APAC: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.4.3.6.3 Rest of APAC: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.4.3.6.3.1 Rest of APAC: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.4.3.6.4 Rest of APAC: Radiopharmaceuticals Market Breakdown, by End User
  • 11.5 Middle East and Africa
    • 11.5.1 Middle East and Africa Radiopharmaceuticals Market Overview
    • 11.5.2 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.5.2.1 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Application
      • 11.5.2.2 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Type
        • 11.5.2.2.1 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Diagnostic
        • 11.5.2.2.2 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Therapeutic
      • 11.5.2.3 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tracer Type
        • 11.5.2.3.1 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tc-99m
      • 11.5.2.4 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by End User
    • 11.5.3 Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Country
      • 11.5.3.1 Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.1.1 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Application
        • 11.5.3.1.2 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Type
        • 11.5.3.1.2.1 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.5.3.1.2.2 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.5.3.1.3 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.5.3.1.3.1 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.5.3.1.4 Saudi Arabia: Radiopharmaceuticals Market Breakdown, by End User
      • 11.5.3.2 South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.2.1 South Africa: Radiopharmaceuticals Market Breakdown, by Application
        • 11.5.3.2.2 South Africa: Radiopharmaceuticals Market Breakdown, by Type
        • 11.5.3.2.2.1 South Africa: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.5.3.2.2.2 South Africa: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.5.3.2.3 South Africa: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.5.3.2.3.1 South Africa: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.5.3.2.4 South Africa: Radiopharmaceuticals Market Breakdown, by End User
      • 11.5.3.3 United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.3.1 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Application
        • 11.5.3.3.2 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Type
        • 11.5.3.3.2.1 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.5.3.3.2.2 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.5.3.3.3 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.5.3.3.3.1 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.5.3.3.4 United Arab Emirates: Radiopharmaceuticals Market Breakdown, by End User
      • 11.5.3.4 Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.5.3.4.1 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Application
        • 11.5.3.4.2 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Type
        • 11.5.3.4.2.1 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.5.3.4.2.2 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.5.3.4.3 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.5.3.4.3.1 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.5.3.4.4 Rest of Middle East and Africa: Radiopharmaceuticals Market Breakdown, by End User
  • 11.6 South and Central America
    • 11.6.1 South and Central America Radiopharmaceuticals Market Overview
    • 11.6.2 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
      • 11.6.2.1 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Application
      • 11.6.2.2 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Type
        • 11.6.2.2.1 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Diagnostic
        • 11.6.2.2.2 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Therapeutic
      • 11.6.2.3 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tracer Type
        • 11.6.2.3.1 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Tc-99m
      • 11.6.2.4 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by End User
    • 11.6.3 South and Central America: Radiopharmaceuticals Market - Revenue and Forecast Analysis - by Country
      • 11.6.3.1 Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.3.1.1 Brazil: Radiopharmaceuticals Market Breakdown, by Application
        • 11.6.3.1.2 Brazil: Radiopharmaceuticals Market Breakdown, by Type
        • 11.6.3.1.2.1 Brazil: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.6.3.1.2.2 Brazil: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.6.3.1.3 Brazil: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.6.3.1.3.1 Brazil: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.6.3.1.4 Brazil: Radiopharmaceuticals Market Breakdown, by End User
      • 11.6.3.2 Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.3.2.1 Argentina: Radiopharmaceuticals Market Breakdown, by Application
        • 11.6.3.2.2 Argentina: Radiopharmaceuticals Market Breakdown, by Type
        • 11.6.3.2.2.1 Argentina: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.6.3.2.2.2 Argentina: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.6.3.2.3 Argentina: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.6.3.2.3.1 Argentina: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.6.3.2.4 Argentina: Radiopharmaceuticals Market Breakdown, by End User
      • 11.6.3.3 Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.6.3.3.1 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by Application
        • 11.6.3.3.2 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by Type
        • 11.6.3.3.2.1 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by Diagnostic
        • 11.6.3.3.2.2 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by Therapeutic
        • 11.6.3.3.3 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by Tracer Type
        • 11.6.3.3.3.1 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by Tc-99m
        • 11.6.3.3.4 Rest of South and Central America: Radiopharmaceuticals Market Breakdown, by End User

12. Radiopharmaceuticals Market-Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in the Radiopharmaceuticals Market
  • 12.3 Inorganic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Organic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Cardinal Health Inc
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Curium
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 General Electric Co
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Medi-Radiopharma
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Rotem Industries Ltd
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 ABX advanced biochemical compounds GmbH
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Invicro LLC
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Newcastle University
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Novartis AG
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Blue Earth Diagnostics Limited
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments
  • 13.11 IBA Radiopharma Solutions
    • 13.11.1 Key Facts
    • 13.11.2 Business Description
    • 13.11.3 Products and Services
    • 13.11.4 Financial Overview
    • 13.11.5 SWOT Analysis
    • 13.11.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. Radiopharmaceuticals Market Segmentation
  • Table 2. Regional Pricing Analysis, US$ (Per Dose), 2023
  • Table 3. Ongoing Targeted Alpha Therapy Clinical Trials
  • Table 4. Physical Half-Lives of Some Medical Radionuclides for Diagnostic and Therapeutic Use
  • Table 5. Some Other Radionuclides Used in Diagnostic Radiopharmaceuticals
  • Table 6. Some Other Radionuclides Used in Therapeutic Radiopharmaceuticals
  • Table 7. Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - By Diagnostic
  • Table 8. Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - By Therapeutic
  • Table 9. Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - By Tc-99m
  • Table 10. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 11. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 12. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 13. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 14. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 15. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 16. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 17. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 18. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 19. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 20. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 21. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 22. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 23. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 24. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 25. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 26. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 27. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 28. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 29. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 30. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 31. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 32. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 33. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 34. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 35. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 36. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 37. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 38. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 39. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 40. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 41. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 42. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 43. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 44. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 45. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 46. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 47. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 48. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 49. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 50. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 51. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 52. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 53. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 54. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 55. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 56. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 57. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 58. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 59. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 60. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 61. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 62. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 63. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 64. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 65. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 66. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 67. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 68. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 69. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 70. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 71. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 72. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 73. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 74. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 75. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 76. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 77. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 78. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 79. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 80. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 81. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 82. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 83. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 84. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 85. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 86. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 87. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 88. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 89. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 90. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 91. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 92. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 93. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 94. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 95. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 96. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 97. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 98. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 99. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 100. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 101. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 102. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 103. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 104. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 105. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 106. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 107. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 108. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 109. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 110. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 111. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 112. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 113. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 114. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 115. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 116. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 117. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 118. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 119. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 120. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 121. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 122. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 123. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 124. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 125. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 126. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 127. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 128. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 129. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 130. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 131. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 132. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 133. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 134. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 135. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 136. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 137. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 138. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 139. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 140. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 141. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 142. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 143. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 144. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 145. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 146. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 147. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 148. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 149. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 150. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 151. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 152. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 153. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 154. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 155. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 156. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 157. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 158. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 159. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 160. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 161. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 162. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 163. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 164. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 165. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 166. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 167. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 168. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 169. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 170. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 171. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 172. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 173. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 174. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 175. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 176. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 177. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 178. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 179. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 180. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 181. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 182. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 183. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 184. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 185. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 186. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 187. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 188. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 189. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 190. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 191. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 192. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Application
  • Table 193. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Type
  • Table 194. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Diagnostic
  • Table 195. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic
  • Table 196. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tracer Type
  • Table 197. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by Tc-99m
  • Table 198. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million) - by End User
  • Table 199. Recent Inorganic Growth Strategies in the Radiopharmaceuticals Market
  • Table 200. Recent Organic Growth Strategies in the Radiopharmaceuticals Market
  • Table 201. Glossary of Terms, Radiopharmaceuticals Market

List Of Figures

  • Figure 1. Radiopharmaceuticals Market Segmentation, by Geography
  • Figure 2. PEST Analysis
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Radiopharmaceuticals Market Revenue (US$ Million), 2023-2031
  • Figure 5. Bioprocessing Market Breakdown by Geography, 2023 and 2031 (%)
  • Figure 6. Radiopharmaceuticals Market Share (%) - by Application (2023 and 2031)
  • Figure 7. Oncology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cardiology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Neurology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Pulmonary: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Urology: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Others: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Radiopharmaceuticals Market Share (%) - by Type (2023 and 2031)
  • Figure 14. Diagnostic: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Therapeutic: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Radiopharmaceuticals Market Share (%) - by Tracer Type (2023 and 2031)
  • Figure 17. Tc-99m: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. F-18: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Ga-68: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. TL-201: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. I-131: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Fe-59: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Lu-171: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. RB-82 and N-13: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 25. Cr-51 and P-32: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Sc-46: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Sg-269 and Hs-269: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Others: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Radiopharmaceuticals Market Share (%) - by End User (2023 and 2031)
  • Figure 30. Hospitals and Clinics: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Diagnostic Centers: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Academic and Research Institutes: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Others: Radiopharmaceuticals Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 34. Radiopharmaceuticals Market Breakdown by Region, 2023 and 2031 (%)
  • Figure 35. North America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. North America: Radiopharmaceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 37. United States: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Canada: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Mexico: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Europe: Radiopharmaceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. Germany: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. United Kingdom: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. France: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Italy: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 46. Spain: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. Rest of Europe: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 48. Asia Pacific: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. Asia Pacific: Radiopharmaceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 50. China: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 51. Japan: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 52. India: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 53. Australia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 54. South Korea: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 55. Rest of APAC: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 56. Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 57. Middle East and Africa: Radiopharmaceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 58. Saudi Arabia: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 59. South Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 60. United Arab Emirates: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 61. Rest of Middle East and Africa: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 62. South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 63. South and Central America: Radiopharmaceuticals Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 64. Brazil: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 65. Argentina: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 66. Rest of South and Central America: Radiopharmaceuticals Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 67. Growth Strategies in the Radiopharmaceuticals Market